Publications by authors named "Emma Hegermiller"

T lymphocyte acute lymphoblastic leukemia (T-ALL) is frequently associated with increased expression of the E protein transcription factor inhibitors TAL1 and LYL1. In mouse models, ectopic expression of TAL1 or LYL1 in T cell progenitors, or inactivation of E2A, is sufficient to predispose mice to develop T-ALL. How E2A suppresses thymocyte transformation is currently unknown.

View Article and Find Full Text PDF

T lymphocyte acute lymphoblastic leukemia (T-ALL) is frequently associated with increased expression of the E protein transcription factor inhibitors TAL1 and LYL1. In mouse models, ectopic expression of Tal1 or Lyl1 in T cell progenitors or inactivation of E2a, is sufficient to predispose mice to develop T-ALL. How E2a suppresses thymocyte transformation is currently unknown.

View Article and Find Full Text PDF

Objectives: Unrecognized clinical deterioration during illness requiring hospitalization is associated with high risk of mortality and long-term morbidity among children. Our objective was to develop and externally validate machine learning algorithms using electronic health records for identifying ICU transfer within 12 hours indicative of a child's condition.

Design: Observational cohort study.

View Article and Find Full Text PDF

Unlabelled: Firearm injury accounts for significant morbidity with high mortality among children admitted to the PICU. Understanding risk factors for PICU admission is an important step toward developing prevention and intervention strategies to minimize the burden of pediatric gunshot wound (GSW) injury.

Objectives: The primary objective of this study was to characterize outcomes and the likelihood of PICU admission among children with GSWs.

View Article and Find Full Text PDF

Gaining a mechanistic understanding of the expansion and maturation program of natural killer (NK) cells will provide opportunities for harnessing their inflammation-inducing and oncolytic capacity for therapeutic purposes. Here, we demonstrated that ID2, a transcriptional regulatory protein constitutively expressed in NK cells, supports NK cell effector maturation by controlling the amplitude and temporal dynamics of the transcription factor TCF1. TCF1 promotes immature NK cell expansion and restrains differentiation.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on improving the delivery of cancer treatments using nanotechnology, specifically targeting metastatic tumors in prostate cancer models that lack certain tumor suppressor genes.
  • Researchers found that cabozantinib not only treats cancer but also activates neutrophils to help deliver BSA-coated nanoparticles (BSA-NPs) directly to tumors, significantly enhancing their uptake.
  • Results showed a substantial increase in BSA-NP accumulation in tumors when combined with cabozantinib, while also reducing delivery to the liver, highlighting a promising approach to improve cancer therapy effectiveness and reduce side effects.
View Article and Find Full Text PDF